Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Id | http://purl.obolibrary.org/obo/NCIT_C29345
http://purl.obolibrary.org/obo/NCIT_C29345
|
|---|---|
| Preferred Name | Pancrelipase |
| Definitions |
A standardized enzyme concentrate containing the pancreatic enzymes, lipase, protease and amylase used in enzyme substitution therapy. Lipase, protease and amylase break down fat, protein, and starches, respectively in the small intestine, thereby promoting digestion. Pancrelipase is used to reduce malabsorption when the pancreas is unable to secrete sufficient amounts of these enzymes.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A standardized enzyme concentrate containing the pancreatic enzymes, lipase, protease and amylase used in enzyme substitution therapy. Lipase, protease and amylase break down fat, protein, and starches, respectively in the small intestine, thereby promoting digestion. Pancrelipase is used to reduce malabsorption when the pancreas is unable to secrete sufficient amounts of these enzymes. |
|---|---|
| label |
Pancrelipase
|
| prefLabel |
Pancrelipase
|
| Legacy Concept Name |
Pancrelipase
|
| in_subset | |
| Preferred_Name |
Pancrelipase
|
| Display_Name |
Pancrelipase
|
| PDQ_Open_Trial_Search_ID |
43514
|
| UMLS_CUI |
C0770343
|
| FDA_UNII_Code |
FQ3DRG0N5K
|
| prefixIRI |
NCIT:C29345
|
| Accepted_Therapeutic_Use_For |
exocrine pancreatic insufficiency; pancreatic enzyme deficiency
|
| NCI_Drug_Dictionary_ID |
43514
|
| Contributing_Source |
CTRP
FDA
|
| subClassOf | |
| code |
C29345
|
| type | |
| PDQ_Closed_Trial_Search_ID |
43514
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| CAS_Registry |
53608-75-6
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |